Angelo Sambunaris, MD
- 2Articles
- 6.6KReads
- 1997–2013Active
- 11Collaborators
- 45Citations
About
Angelo Sambunaris, MD, has contributed to research on major depressive disorder, focusing on the efficacy and safety of pharmacological treatments. His work includes studies on lisdexamfetamine dimesylate as augmentation therapy for residual symptoms of depression and the development of new antidepressants. Sambunaris has collaborated with co-authors such as Andrew J. Cutler and Ashwin A. Patkar. His publications appeared between 1997 and 2013 in Psychiatrist.com journals.
Publications
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
